Ambrisentan Devatis 5 mg
Ambrisentan Devatis 5 mg is a medicine authorised by Swissmedic under authorisation number 67799. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 October 2020 and the authorisation is valid without a time limit. ATC code C02KX02 places the medicine in the group Antihypertensives.
| Authorisation number | 67799 |
|---|---|
| Name | Ambrisentan Devatis 5 mg |
| Full name | Ambrisentan Devatis 5 mg, Filmtabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02KX02 |
| First authorisation | 29 October 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ambrisentan Devatis 5 mg, Filmtabletten | B | 29 October 2020 |
| 2 | Ambrisentan Devatis 10 mg, Filmtabletten | B | 29 October 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | C02KX02 | 02.07.1. | B |
| 2 | 30 | Tablette(n) | C02KX02 | 02.07.1. | B |
| 3 | 10 | Tablette(n) | C02KX02 | 02.07.1. | B |
| 4 | 30 | Tablette(n) | C02KX02 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ambrisentan Devatis 5 mg authorised in Switzerland?
Yes. Ambrisentan Devatis 5 mg is authorised by Swissmedic under authorisation number 67799, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ambrisentan Devatis 5 mg have?
Ambrisentan Devatis 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ambrisentan Devatis 5 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.